Melanoma Skin Cancer: A Comprehensive Review of Current Knowledge
Cancers · 05.09.2025 · 17 (17) · 2920
DOI: 10.3390/cancers17172920 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 05.09.2025. Verfasst von Camila Caraviello und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiopathology and Transplantation, University of Milan, 20122 Milan, Italy. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 273 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cutaneous melanoma is the most severe form of skin cancer. The incidence of the disease has been increasing in the last decades, largely due to increased ultraviolet radiation exposure. A comprehensive understanding of the complex biological processes involved in melanoma development and progression is essential for advancing patient care. Improvement in surveillance strategies, widespread use of sentinel lymph node biopsy, and breakthroughs in systemic therapy have all contributed considerably to enhancing patient outcomes and survival. Rapid advancements in melanoma management are expected to continue, particularly through innovations in molecular biology and genetics. These emerging technologies aim to enhance diagnostic accuracy, predict disease progression, and improve prognosis. Staying informed about these evolving developments is essential for professionals dealing with melanoma patients. This narrative review provides a comprehensive overview of the current state of cutaneous melanoma, covering fundamental areas, such as histopathology, genetics, epidemiology, diagnosis, and staging. It provides a foundation to enhance understanding of current treatment approaches and the principles behind emerging technologies. This review also highlights future directions in melanoma care, including improvements in neoadjuvant therapy, use of artificial intelligence-based algorithms, use of molecular biomarkers to improve diagnosis and prognosis, and development of personalized neoantigen mRNA vaccines. Ultimately, this review aims to support clinicians in understanding the current landscape and anticipated innovations in melanoma management to improve clinical decision-making.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiopathology and Transplantation, University of Milan, 20122 Milan, Italy.
- SC Dermatologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
- Pathology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
- SC Oncologia Medica, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
ORCID-Profile: Camila Caraviello, Gianluca Nazzaro, Gianluca Tavoletti, Francesca Boggio, Nerina Denaro, Angelo Valerio Marzano
Zitieren
APA
Caraviello, C., Nazzaro, G., Tavoletti, G., Boggio, F., Denaro, N., Murgia, G., Passoni, E., Benzecry Mancin, V., & Marzano, A. V. (2025). Melanoma Skin Cancer: A Comprehensive Review of Current Knowledge. Cancers, 17(17), 2920. https://doi.org/10.3390/cancers17172920
Vancouver
Caraviello C, Nazzaro G, Tavoletti G, Boggio F, Denaro N, Murgia G, et al. Melanoma Skin Cancer: A Comprehensive Review of Current Knowledge. Cancers. 2025;17(17):2920. doi:10.3390/cancers17172920
BibTeX
@article{Caraviello2025,
author = {Caraviello, Camila and Nazzaro, Gianluca and Tavoletti, Gianluca and Boggio, Francesca and Denaro, Nerina and Murgia, Giulia and Passoni, Emanuela and Benzecry Mancin, Valentina and Marzano, Angelo Valerio},
title = {Melanoma Skin Cancer: A Comprehensive Review of Current Knowledge},
journal = {Cancers},
year = {2025},
volume = {17},
number = {17},
pages = {2920},
doi = {10.3390/cancers17172920}
}
EUVIMED